PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilians-Universität München.\', \'Rheumatologisches Praxiszentrum München, München.\', \'Division of Rheumatology, Department of Medicine 1, University Hospital Schleswig-Holstein Campus Kiel, Kiel.\', \'Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg.\', \'Department of Medicine III and Section Rheumatology, University Hospital Hamburg-Eppendorf, Hamburg.\', \'Clinic for Rheumatology and Clinical Immunology, Kliniken Essen-Mitte, Essen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/rheumatology/keab072
?:hasPublicationType
?:journal
  • Rheumatology (Oxford, England)
is ?:pmid of
?:pmid
?:pmid
  • 33502500
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all